| AURKA (AurA) | Aur | Other | 3efw | A | | 1-[3-methyl-4-({3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl}oxy)phenyl]-3-[3-(trifluoromethyl)phenyl]urea | Human | 2010 | 0.54 | |
| EPHA2 (EphA2) | Eph | TK | 6q7g | A | A | 3-[(4-imidazol-1-yl-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11933 | 0.43 | |
| EPHA2 (EphA2) | Eph | TK | 6q7g | A | C | 3-[(4-imidazol-1-yl-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11934 | 0.43 | |
| EPHA2 (EphA2) | Eph | TK | 6q7g | A | B | 3-[(4-imidazol-1-yl-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11938 | 0.43 | |
| BRAF | RAF | TKL | 5vam | B | A | n-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide | Human | 8186 | 0.43 | |
| MAPK11 (p38b) | MAPK | CMGC | 3gp0 | A | A | nilotinib | Human | 2768 | 0.40 | |
| MAPK11 (p38b) | MAPK | CMGC | 3gp0 | A | B | nilotinib | Human | 2764 | 0.40 | |
| SRPK2 | SRPK | CMGC | 5myv | B | B | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7573 | 0.40 | |
| BRAF | RAF | TKL | 8f7p | A | B | n-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide | Human | 14702 | 0.40 | |
| BRAF | RAF | TKL | 8f7p | A | A | n-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide | Human | 14705 | 0.40 | |
| ABL1 | Abl | TK | 3cs9 | C | A | nilotinib | Human | 1046 | 0.40 | |
| ERN1 (IRE1) | IRE | Other | 6w3e | B | | methyl ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]carbamate | Human | 13126 | 0.41 | |
| KDR | VEGFR | TK | 3ewh | A | | n-[4-({3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl}oxy)naphthalen-1-yl]-6-(trifluoromethyl)-1h-benzimidazol-2-amine | Human | 5351 | 0.47 | |
| AURKA (AurA) | Aur | Other | 3efw | B | | 1-[3-methyl-4-({3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl}oxy)phenyl]-3-[3-(trifluoromethyl)phenyl]urea | Human | 2074 | 0.54 | |
| ABL1 | Abl | TK | 3cs9 | A | A | nilotinib | Human | 1080 | 0.40 | |
| ERN1 (IRE1) | IRE | Other | 6w3a | B | B | ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]but-2-ynamide | Human | 13119 | 0.43 | |
| ERN1 (IRE1) | IRE | Other | 6w3a | A | A | ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]but-2-ynamide | Human | 13125 | 0.43 | |
| ERN1 (IRE1) | IRE | Other | 6w3e | A | | methyl ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]carbamate | Human | 13121 | 0.41 | |
| SRPK1 | SRPK | CMGC | 5mxx | A | B | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 9467 | 0.40 | |
| ERN1 (IRE1) | IRE | Other | 6w39 | B | B | ethyl ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]carbamate | Human | 13124 | 0.41 | |
| ABL1 | Abl | TK | 5mo4 | A | B | nilotinib | Human | 7526 | 0.40 | |
| ERN1 (IRE1) | IRE | Other | 6w3a | B | A | ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]but-2-ynamide | Human | 13118 | 0.43 | |
| AURKA (AurA) | Aur | Other | 3o50 | B | | n-{3-methyl-4-[(3-pyrimidin-4-ylpyridin-2-yl)oxy]phenyl}-3-(trifluoromethyl)benzamide | Human | 2067 | 0.47 | |
| ABL1 | Abl | TK | 3cs9 | B | B | nilotinib | Human | 1112 | 0.40 | |
| BRAF | RAF | TKL | 5vam | B | B | n-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide | Human | 8187 | 0.43 | |
| AURKA (AurA) | Aur | Other | 3o50 | A | | n-{3-methyl-4-[(3-pyrimidin-4-ylpyridin-2-yl)oxy]phenyl}-3-(trifluoromethyl)benzamide | Human | 1958 | 0.47 | |
| BRAF | RAF | TKL | 6n0p | A | A | n-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide | Human | 11597 | 0.40 | |
| BRAF | RAF | TKL | 6n0p | A | B | n-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide | Human | 11596 | 0.40 | |
| SRPK2 | SRPK | CMGC | 5myv | A | B | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7575 | 0.40 | |
| SRPK2 | SRPK | CMGC | 5myv | A | A | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7579 | 0.40 | |
| SRPK2 | SRPK | CMGC | 5myv | C | A | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7580 | 0.40 | |
| BRAF | RAF | TKL | 5vam | A | B | n-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide | Human | 8189 | 0.43 | |
| ABL1 | Abl | TK | 5mo4 | A | A | nilotinib | Human | 7527 | 0.40 | |
| BRAF | RAF | TKL | 6n0p | B | B | n-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide | Human | 11595 | 0.40 | |
| ERN1 (IRE1) | IRE | Other | 6w39 | A | A | ethyl ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]carbamate | Human | 13120 | 0.41 | |
| SRPK2 | SRPK | CMGC | 5myv | B | A | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7576 | 0.40 | |
| ERN1 (IRE1) | IRE | Other | 6w3a | A | B | ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]but-2-ynamide | Human | 13116 | 0.43 | |
| SRPK2 | SRPK | CMGC | 5myv | D | B | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7572 | 0.40 | |
| ERN1 (IRE1) | IRE | Other | 6w39 | B | A | ethyl ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]carbamate | Human | 13117 | 0.41 | |
| ABL1 | Abl | TK | 3cs9 | B | A | nilotinib | Human | 1050 | 0.40 | |
| SRPK2 | SRPK | CMGC | 5myv | C | B | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7571 | 0.40 | |
| SRPK1 | SRPK | CMGC | 4wua | A | A | n-[2-(1-piperidinyl)-5-(trifluoromethyl)phenyl]-4-pyridinecarboxamide | Human | 9471 | 0.45 | |
| ERN1 (IRE1) | IRE | Other | 6w39 | A | B | ethyl ~{n}-[6-methyl-5-[3-[2-[[(3~{s})-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxy-naphthalen-1-yl]carbamate | Human | 13122 | 0.41 | |
| ABL1 | Abl | TK | 3cs9 | C | B | nilotinib | Human | 1093 | 0.40 | |
| ABL1 | Abl | TK | 3cs9 | D | B | nilotinib | Human | 1066 | 0.40 | |
| ABL1 | Abl | TK | 3cs9 | A | B | nilotinib | Human | 1107 | 0.40 | |
| MAPK10 (JNK3) | MAPK | CMGC | 3da6 | A | | n-[3-methyl-4-({3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl}oxy)naphthalen-1-yl]-1h-benzimidazol-2-amine | Human | 3476 | 0.41 | |
| TEK (TIE2) | Tie | TK | 2p4i | B | | 4-methyl-3-({3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl}oxy)-n-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]benzamide | Human | 5550 | 1.00 | |
| TEK (TIE2) | Tie | TK | 2p4i | A | | 4-methyl-3-({3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl}oxy)-n-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]benzamide | Human | 5549 | 1.00 | |
| TEK (TIE2) | Tie | TK | 2osc | A | | n-{4-methyl-3-[(3-pyrimidin-4-ylpyridin-2-yl)amino]phenyl}-3-(trifluoromethyl)benzamide | Human | 5555 | 0.40 | |
| SRPK1 | SRPK | CMGC | 4wua | A | B | n-[2-(1-piperidinyl)-5-(trifluoromethyl)phenyl]-4-pyridinecarboxamide | Human | 9469 | 0.45 | |
| SRPK1 | SRPK | CMGC | 5my8 | A | A | sphinx31 | Human | 9466 | 0.40 | |
| SRPK1 | SRPK | CMGC | 5my8 | A | B | sphinx31 | Human | 9468 | 0.40 | |
| ABL1 | Abl | TK | 3cs9 | D | A | nilotinib | Human | 1077 | 0.40 | |
| SRPK2 | SRPK | CMGC | 5myv | D | A | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 7578 | 0.40 | |
| SRPK1 | SRPK | CMGC | 5mxx | A | A | 5-methyl-~{n}-[2-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide | Human | 9470 | 0.40 | |
| BRAF | RAF | TKL | 5vam | A | A | n-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide | Human | 8185 | 0.43 | |
| BRAF | RAF | TKL | 6n0p | B | A | n-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide | Human | 11594 | 0.40 | |